Creator of biosourced 100% molecules of interest for the cosmetics and fine chemicals sectors
After 15 years of research in ecological chemistry within the ChimEco laboratory, Prof. Claude Grison joined forces with Technofounders to create BioInspir in 2020, with the aim of commercialising the production of biosourced and natural molecules for the cosmetics and fine chemicals sectors.
BioInspir selects certain plant species capable of biosorbing metals contained in natural or industrial effluents. The use of these plants makes it possible to create filters to capture the metals, and from these, to design ecocatalysts used for the soft synthesis of high added value products.
Today, the company has a library of molecules that evolves day by day. New molecules are developed every week, either on a contract basis for clients or on molecules with a high stake for numerous companies.
After securing nearly €1 million in funding in September 2020, BioInspir is developing its molecule library and preparing to scale up to kilo-lab size.
BIOINSPIR accelerates its growth and secures nearly €1 million in financingMontpellier, 9 September 2020 - The result of 15 years of research by Claude Grison and the ChimEco laboratory, Bioinspir synthesises molecules for fine chemistry from its unique ecocatalysis platform. Only a few months after its creation, the deeptech start-up has secured nearly €1 million in funding to support its first commercial phase. In recent weeks, the start-up has completed a financing round with TechnoFounders Participations, was a winner of the i-Nov innovation competition and was awarded the French Tech Emergence grant. All announcements and information from the press release here
A spin-off from the ChimEco laboratory at the University of Montpellier, the start-up Bioinspir has developed a plant-based filter to capture metals in polluted water. Designed from invasive aquatic plants, it can then be reused for other applications. Discussions are underway with chemical companies. Suite.
Mibelle Biochemistry designs and develops unique, high-quality active ingredients for the cosmetics industry, based on natural substances and high scientific expertise.
This independent business unit within the Mibelle Group was founded in 1995 by Dr Fred Zülli in Buchs, Switzerland.
In a short period of time, Mibelle Biochemistry has built an excellent reputation worldwide as a creator of innovative active ingredient concepts and a true expert in the fields of biotechnology and biochemistry. Its wide range of active ingredients is available in over 50 countries worldwide.
Our slogan "Inspired by nature - Realized by science" reflects our philosophy.
Our experts transform natural plant compounds into bioactive cosmetic ingredients. Our R&D team uses encapsulation technologies that guarantee optimal bioavailability and thus ensure maximum effectiveness of the active ingredients.
Commitment to sustainable development is at the heart of our business and continues to grow.
Visio-Conference Biomim'SCOPE, BIOMIMÉTISME ... & COSMÉTIQUE - Review of trends, news and prospects, and presentation of the latest bio-inspired innovations by Mibelle. With Vincent Briffaut, Sales Director France, and Stéphane Poigny, R&D Director France, Mibelle Biochemistry France.
BIOTECHNOLOGIES AND BIO-INSPIRATION OR THE FUTURE OF THE COSMETIC REVOLUTION. Vincent Briffaut interviewed by Nicolas Doze on BFM BUSINESS.
The AlgoSource group, a recognised world expert in microalgae, offers a complete range of services from production engineering to the industrial valorisation of microalgae. Its unique know-how covers all the processes involved in the production and transformation of microalgae and provides an integrated vision for its industrial clients.
AlgoSource is developing 4 main areas for its industrial clients and consumers:
Production of microalgae in controlled systems (photobioreactors)
Biorefinery engineering (custom extraction of molecules)
Production and sale of natural products "made in France" (see our Alpha Biotech shop)
Integrated system design (design of photobioreactors from 1 litre to several m3)
We are developing a bioluminescent raw material made from natural and infinitely cultivable micro-organisms. Our core business is biotechnology. We improve (without genetic modification) these micro-organisms to make them more efficient in terms of light production (intensity, stability, efficiency).
Sustainable light systems for the landscape of tomorrow
In collaboration with energy companies, real estate groups, architects, local authorities, artists, construction companies, landscapers and hotels, Glowee meets your sustainable lighting needs.
Let's create together the uses of bioluminescence of tomorrow!
The Ceramic Synthesis and Functionalization Laboratory is a joint CNRS / Saint-Gobain research unit, doing fundamental research on functional ceramic materials, in particular ceramic materials having charge transfer properties. More specifically, we study how the combination of functional properties can lead to innovative materials.
We focus on three scientific topics:
Control the hierarchic porosity in the materials
Control the microstructure of ceramic materials at the grain scale in order to optimise their functional properties (including ionic conductivity)
Understand the interaction of the surface of ion-conducting materials with gaseous reactive species
M2i Life Sciences is an industrial player in the chemical industry, active in the animal and plant bio-control sector as well as in the field of human health. Biocontrol is the set of biological protection methods that replicate intra-species behaviours and natural mechanisms of regulation of bio-aggressors.
M2i Life Sciences is a world leader in pheromones for crop protection and animal health.
We master :
The synthesis of pheromonal molecules
The production of these pheromones from gram to ton
The formulation of these pheromones and the delivery systems
Design and production of finished products
We combine R&D know-how, a production plant and a manufacturing centre for finished products, which allows us to control the entire product development cycle and to integrate innovation at every stage of its design.
TISSIUM™ invents the next generation of synthetic polymers for tissue reconstruction :
BIOMORPHIC : Conforms to and integrates with surrounding tissue to enable natural healing
PROGRAMMABLE : Modular polymer design can be adjusted to match tissue-specific requirements
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialisation and manufacturing platform to support our internal programmes as well as co-development partnerships with leaders in the medtech industry.